Literature DB >> 24082772

Cataracts among adults aged 30 to 49 years: a 10-year study from 1995 to 2004 in Korea.

Hyun Kyung Cho1, Kyung Sun Na, Eun Jung Jun, Sung Kun Chung.   

Abstract

PURPOSE: To investigate the long-term characteristics of cataracts among adults aged 30 to 49 years in Korean over a span of 10 years.
METHODS: Subjects between the ages of 30 to 49 years who underwent cataract surgery at St. Mary's Hospital from 1995 to 2004 (n = 976) were included. Patients with a history of ocular trauma, uveitis, other ocular or systemic diseases, and congenital cataracts were excluded. Additional information including type of lens opacity, urban/rural region, and pre- and postoperative visual acuities were analyzed. Lens opacity grading was conducted using Lens Opacity Classification System III. The Cochran-Armitage proportion trend test was used to analyze vision changes with the passage of time.
RESULTS: Among the patients who had undergone cataract surgeries, 8.8% (976 / 11,111) met the inclusion criteria. The mean age was 41.7 ± 5.45 years. Gender breakdown of the patient population included 79.0% male and 21.0% female. In terms of home environment, 60.9% were from an urban region and 39.1% from a rural region. Opacity type included anterior polar (AP), posterior subcapsular (PSC), AP and PSC, cortical, and nuclear in 35.7%, 35.1%, 7.0%, 6.0%, and 5.4% of patients, respectively. At a 2-month postoperative follow-up appointment, 92.7% of patients showed a best-corrected visual acuity of more than 20 / 40.
CONCLUSIONS: Predominance of AP and PSC opacities as well as male patients was observed in this study population.

Entities:  

Keywords:  Anterior polar opacity; Epidemiology; Korea; Posterior subcapsular opacity

Mesh:

Year:  2013        PMID: 24082772      PMCID: PMC3782580          DOI: 10.3341/kjo.2013.27.5.345

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  30 in total

Review 1.  Congenital cataract and multisystem disorders.

Authors:  L Cassidy; D Taylor
Journal:  Eye (Lond)       Date:  1999-06       Impact factor: 3.775

2.  The epidemiology of cataract in Australia.

Authors:  C A McCarty; B N Mukesh; C L Fu; H R Taylor
Journal:  Am J Ophthalmol       Date:  1999-10       Impact factor: 5.258

3.  Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan.

Authors:  Su-Ying Tsai; Wen-Ming Hsu; Ching-Yu Cheng; Jorn-Hon Liu; Pesus Chou
Journal:  Ophthalmology       Date:  2003-06       Impact factor: 12.079

4.  Glare and contrast: indications for cataract surgery.

Authors:  N S Jaffe
Journal:  J Cataract Refract Surg       Date:  1986-07       Impact factor: 3.351

5.  Vision through cataracts.

Authors:  R Hess; G Woo
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-05       Impact factor: 4.799

6.  Evaluation of indications for cataract surgery.

Authors:  A A Cinotti
Journal:  Ophthalmic Surg       Date:  1979-12

7.  Functional vision with cataracts of different morphologies: comparative study.

Authors:  Eva Stifter; Stefan Sacu; Herbert Weghaupt
Journal:  J Cataract Refract Surg       Date:  2004-09       Impact factor: 3.351

8.  The prevalence of nuclear, cortical, and posterior subcapsular lens opacities in a general population sample.

Authors:  R D Sperduto; R Hiller
Journal:  Ophthalmology       Date:  1984-07       Impact factor: 12.079

9.  Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008-2009.

Authors:  Kyung-Chul Yoon; Gui-Hyeong Mun; Sang-Duck Kim; Seung-Hyun Kim; Chan Yun Kim; Ki Ho Park; Young Jeung Park; Seung-Hee Baek; Su Jeong Song; Jae Pil Shin; Suk-Woo Yang; Seung-Young Yu; Jong Soo Lee; Key Hwan Lim; Hye-Jin Park; Eun-Young Pyo; Ji-Eun Yang; Young-Taek Kim; Kyung-Won Oh; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2011-11-22

10.  Congenital cataract: etiology and morphology.

Authors:  I S Jain; P Pillay; D N Gangwar; S P Dhir; V K Kaul
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1983 Nov-Dec       Impact factor: 1.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.